[1]
2021. Neurotropismo de SARS-CoV-2: Possíveis impactos da COVID-19 em portadores de Esclerose Lateral Amiotrófica . Research, Society and Development. 10, 7 (jun. 2021), e28310716441. DOI:https://doi.org/10.33448/rsd-v10i7.16441.